David Ross Parkinson's Net Worth

$842 Thousand

Estimate Recalculated Jul 3, 2024 11:20AM EST

Who is David Ross Parkinson?

David Ross Parkinson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include FACET BIOTECH CORP, CTI BIOPHARMA CORP, ESSA Pharma Inc., Tocagen Inc, Cerulean Pharma Inc., THRESHOLD PHARMACEUTICALS INC, and AMBIT BIOSCIENCES CORP.

SEC CIK

David Ross Parkinson's CIK is 0001451935

Past Insider Trading and Trends

2022 was David Ross Parkinson's most active year for acquiring shares with 5 total transactions. David Ross Parkinson's most active month to acquire stocks was the month of April. 2023 was David Ross Parkinson's most active year for disposing of shares, totalling 7 transactions. David Ross Parkinson's most active month to dispose stocks was the month of May. 2022 saw David Ross Parkinson paying a total of $73,497.08 for 331,821 shares, this is the most they've acquired in one year. In 2010 David Ross Parkinson cashed out on 32,500 shares for a total of $877,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

FACET BIOTECH CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.50K
$27.00
-$67,500.00
0
Apr 21
Form 4
-76.92%
-8.33K
$27.00
-$224,991.00
2.5K
Apr 20
Form 4
+30.00%
2.5K
—
—
10.83K
May 26
Form 4
∞
8.33K
—
—
8.33K
Jan 23
Form 3
—
0
—
—
0
No matching records found

CTI BIOPHARMA CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Apr 5
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Jun 5
Form 3
—
0
—
—
0
No matching records found

ESSA Pharma Inc. (EPIX) Snapshot price: $11.3

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 25
Form 4
+16.34%
9.22K
$2.30
$21,212.90
65.67K
Dec 14
Form 4
+76.10%
24.43K
$2.42
$59,041.33
56.54K
Dec 22 - Dec 30
Form 4
—
0
—
—
0
Jun 29
Form 4
+17.95%
4.89K
$2.96
$14,455.75
32.11K
Jun 30
Form 4
—
0
—
—
0
Dec 11
Form 3
—
0
—
—
0
No matching records found

Tocagen Inc (FBRX) Snapshot price: $0.5935

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 4
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Apr 12
Form 3
—
0
—
—
0
No matching records found

Cerulean Pharma Inc. (DARE) Snapshot price: $0.3302

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+132.48%
16.23K
$0.77
$12,500.18
28.49K
Jan 3
Form 4
∞
12.25K
$1.02
$12,499.08
12.25K
Oct 3
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Oct 29
Form 3
—
0
—
—
0
No matching records found